Form 8-K - Current report:
SEC Accession No. 0001746473-22-000030
Filing Date
2022-11-08
Accepted
2022-11-08 16:05:27
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plrx-20221108.htm   iXBRL 8-K 39389
2 EX-99.1 a3q2022exhibit991.htm EX-99.1 82313
6 GRAPHIC image_0.jpg GRAPHIC 13148
  Complete submission text file 0001746473-22-000030.txt   285188

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20221108.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20221108_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20221108_pre.xml EX-101.PRE 12508
8 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20221108_htm.xml XML 11285
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 221368838
SIC: 2834 Pharmaceutical Preparations